Baldwin Wealth Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-141
Closed -$15.6K 347
2024
Q3
$15.6K Buy
+141
New +$14.7K ﹤0.01% 732
2017
Q4
Sell
-33
Closed -$2K 477
2017
Q3
$2K Buy
+33
New +$2.33K ﹤0.01% 462
2016
Q3
Sell
-698
Closed -$54K 540
2016
Q2
$54K Sell
698
-23,147
-97% -$1.85M 0.01% 265
2016
Q1
$1.95M Buy
23,845
+294
+1% +$23.9K 0.35% 63
2015
Q4
$2.1M Sell
23,551
-127,710
-84% -$10.8M 0.34% 69
2015
Q3
$11.6M Sell
151,261
-2,564
-2% -$214K 1.96% 9
2015
Q2
$12.9M Buy
153,825
+3,241
+2% +$286K 1.91% 9
2015
Q1
$13.6M Buy
150,584
+2,188
+1% +$188K 2% 8
2014
Q4
$12M Sell
148,396
-2,900
-2% -$229K 1.73% 13
2014
Q3
$11.3M Buy
151,296
+5,742
+4% +$418K 1.61% 14
2014
Q2
$9.98M Buy
145,554
+11,916
+9% +$811K 1.48% 20
2014
Q1
$9.35M Buy
133,638
+120,753
+937% +$8.4M 1.5% 22
2013
Q4
$861K Buy
+12,885
New +$788K 0.14% 142

Other funds holding CAH

Baldwin Wealth Partners's CAH Position: Q4 2024 in Review

Baldwin Wealth Partners sold out of Cardinal Health (CAH) in Q4 2024, closing a stake of 141 shares — an estimated $15.6K sold.

Baldwin Wealth Partners first reported a position in CAH in Q4 2013 and held it in 13 quarters. The position peaked at $13.6M in Q1 2015. 1,100 funds tracked by Wall St. Rank hold CAH as of Q4 2024.

  • Baldwin Wealth Partners reported no remaining Cardinal Health position as of Q4 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 141 Cardinal Health shares in Q4 2024, an estimated $15.6K.
  • Baldwin Wealth Partners first reported a position in Cardinal Health in Q4 2013 and held it in 13 quarters.
  • Baldwin Wealth Partners's Cardinal Health position peaked at $13.6M in Q1 2015.
  • 1,100 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2024.

Based on Baldwin Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.